437 related articles for article (PubMed ID: 35187675)
21. Natural Compounds in the Chemoprevention of Malignant Melanoma.
Danciu C; Soica C; Antal D; Alexa E; Pavel IZ; Ghiulai R; Ardelean F; Babuta RM; Popescu A; Dehelean CA
Anticancer Agents Med Chem; 2018; 18(5):631-644. PubMed ID: 29173184
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in the Antiproliferative and Proapoptotic Activity of Various Plant Extracts and Constituents against Murine Malignant Melanoma.
Dumitraș DA; Andrei S
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458783
[TBL] [Abstract][Full Text] [Related]
23. Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy.
Shoaib S; Islam N; Yusuf N
Curr Med Chem; 2022; 29(26):4481-4506. PubMed ID: 35232338
[TBL] [Abstract][Full Text] [Related]
24. Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.
Kowalski S; Karska J; Tota M; Skinderowicz K; Kulbacka J; Drąg-Zalesińska M
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338469
[TBL] [Abstract][Full Text] [Related]
25. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
[TBL] [Abstract][Full Text] [Related]
26. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
27. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.
Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y
Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392
[TBL] [Abstract][Full Text] [Related]
28. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells.
George VC; Naveen Kumar DR; Suresh PK; Kumar S; Kumar RA
Asian Pac J Cancer Prev; 2013; 14(2):631-7. PubMed ID: 23621210
[TBL] [Abstract][Full Text] [Related]
29. Epigenetics of skin cancer: Interventions by selected bioactive phytochemicals.
Penta D; Somashekar BS; Meeran SM
Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):42-49. PubMed ID: 28976029
[TBL] [Abstract][Full Text] [Related]
30. Essential oils: from prevention to treatment of skin cancer.
Pavithra PS; Mehta A; Verma RS
Drug Discov Today; 2019 Feb; 24(2):644-655. PubMed ID: 30508640
[TBL] [Abstract][Full Text] [Related]
31. Novel Nanolipoidal Systems for the Management of Skin Cancer.
Singh A; Nimisha
Recent Pat Drug Deliv Formul; 2020; 14(2):108-125. PubMed ID: 32807069
[TBL] [Abstract][Full Text] [Related]
32. Managing Cutaneous Side Effects From Targeted Molecular Inhibitors for Melanoma and Nonmelanoma Skin Cancer.
Tang N; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S40-8. PubMed ID: 26730973
[TBL] [Abstract][Full Text] [Related]
33. Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma.
Basile D; Lisanti C; Pizzichetta MA; Baldo P; Fornasier G; Lo Re F; Corona G; Puglisi F
Recent Pat Anticancer Drug Discov; 2019; 14(3):203-225. PubMed ID: 31362664
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res; 2017 Jul; 185():1-12. PubMed ID: 28528915
[TBL] [Abstract][Full Text] [Related]
35. Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1.
Kim YS; Kim SH; Shin J; Harikishore A; Lim JK; Jung Y; Lyu HN; Baek NI; Choi KY; Yoon HS; Kim KT
PLoS One; 2014; 9(10):e109655. PubMed ID: 25310002
[TBL] [Abstract][Full Text] [Related]
36. Breast Cancer Apoptosis and the Therapeutic Role of Luteolin.
Fasoulakis Z; Koutras A; Syllaios A; Schizas D; Garmpis N; Diakosavvas M; Angelou K; Tsatsaris G; Pagkalos A; Ntounis T; Kontomanolis EN
Chirurgia (Bucur); 2021; 116(2):170-177. PubMed ID: 33950812
[TBL] [Abstract][Full Text] [Related]
37. Novel extraction techniques and pharmaceutical activities of luteolin and its derivatives.
Manzoor MF; Ahmad N; Ahmed Z; Siddique R; Zeng XA; Rahaman A; Muhammad Aadil R; Wahab A
J Food Biochem; 2019 Sep; 43(9):e12974. PubMed ID: 31489656
[TBL] [Abstract][Full Text] [Related]
38. Better targeting melanoma: options beyond surgery and conventional chemotherapy.
Kyrgidis A; Valasidis A; Bourlidou E; Andreadis C
Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):147-59. PubMed ID: 22074588
[TBL] [Abstract][Full Text] [Related]
39. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review.
Pandurangan AK; Esa NM
Asian Pac J Cancer Prev; 2014; 15(14):5501-8. PubMed ID: 25081655
[TBL] [Abstract][Full Text] [Related]
40. New Potential Agents for Malignant Melanoma Treatment-Most Recent Studies 2020-2022.
Kozyra P; Krasowska D; Pitucha M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
